The University of Chicago Header Logo

Connection

Mark Kozloff to Epithelial Cells

This is a "connection" page, showing publications Mark Kozloff has written about Epithelial Cells.
Connection Strength

0.040
  1. A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. Clin Cancer Res. 2022 12 01; 28(23):5040-5048.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.